A randomized double-blind placebo-controlled study

Project: Research project

Description

A randomized double-blind placebo-controlled study to evaluate the efficacy and safety of Cinryze?? (C1 esterase inhibitor [human]) for the treatment of acute antibody-mediated rejection in kidney transplant patients
StatusActive
Effective start/end date6/15/156/14/20

Funding

  • SHIRE HUMAN GENETIC THERAPIES, INC.

Fingerprint

Complement C1 Inhibitor Protein
Placebos
Transplants
Kidney
Safety
Antibodies
Therapeutics
human SERPING1 protein